These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 2470922)

  • 1. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.
    Beeler JA; van Wyke Coelingh K
    J Virol; 1989 Jul; 63(7):2941-50. PubMed ID: 2470922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.
    van Wyke Coelingh K; Tierney EL
    J Virol; 1989 Jan; 63(1):375-82. PubMed ID: 2462062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR
    Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R; Connor A; Gias E; Toms GL
    J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
    Taylor G; Stott EJ; Furze J; Ford J; Sopp P
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
    Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
    J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.
    García-Barreno B; Palomo C; Peñas C; Delgado T; Perez-Breña P; Melero JA
    J Virol; 1989 Feb; 63(2):925-32. PubMed ID: 2463385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.
    Tsutsumi H; Flanagan TD; Ogra PL
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2161-7. PubMed ID: 2440982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay.
    Anderson LJ; Hierholzer JC; Stone YO; Tsou C; Fernie BF
    J Clin Microbiol; 1986 Mar; 23(3):475-80. PubMed ID: 2420819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
    McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
    J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.
    Coelingh KV; Winter CC
    J Virol; 1990 Mar; 64(3):1329-34. PubMed ID: 1689394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes.
    Zhang P; Gu H; Bian C; Liu N; Li Z; Duan Y; Zhang S; Wang X; Yang P
    J Gen Virol; 2014 Sep; 95(Pt 9):1886-1891. PubMed ID: 24914066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virus.
    Langedijk JP; Meloen RH; van Oirschot JT
    Arch Virol; 1998; 143(2):313-20. PubMed ID: 9541615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus.
    West WH; Lounsbach GR; Bourgeois C; Robinson JW; Carter MJ; Crompton S; Duhindan N; Yazici ZA; Toms GL
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2813-9. PubMed ID: 7931172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
    Palomo C; Mas V; Detalle L; Depla E; Cano O; Vázquez M; Stortelers C; Melero JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6498-6509. PubMed ID: 27550346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan.
    Nagai K; Tsutsumi H; Yamazaki H; Pattamadilok S; Chiba S
    Arch Virol; 1993; 128(1-2):55-63. PubMed ID: 7678192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.